UCI: Tour de France champion, Froome failed drugs test

  • Libyan Express + Agencies |
  • Wednesday 13 December 2017

Four-time Tour de France winner Chris Froome. (AFP)

Union Cycliste Internationale (UCI), cycling’s governing body, said on Wednesday, that four-time Tour de France winner Chris Froome failed a drugs test during the Vuelta race in September.

The UCI did not suspend Froome from competing, but asked the British Team Sky driver to provide more information on violating the permitted level of legal asthma medication Salbutamol in his system.

The team said he had taken no more than the permissible amount of Salbutamol, adding that Froome had declared his use of the medication.

The 32-year-old rider suffered from asthma since childhood and had been affected by symptoms during the Vuelta a Espana, the Tour of Spain, which he went on to win.

Froome did not participate in any tournament since then, but he declared his intention to take part in the three major tours, France, Spain and Italy, in 2018.


Comments reflect the opinions of the visitor and not those of Libyan Express, its editorial board or staff.